Cargando…
sRAGE and early signs of cardiac target organ damage in mild hypertensives
BACKGROUND: Soluble Receptor for Advanced Glycation End Products (sRAGE) may be considered a marker inversely related to inflammation and its participation has been established in patients with advanced atherosclerotic vascular diseases. However, it is still unknown whether sRAGE reduction could be...
Autores principales: | Maresca, Andrea Maria, Guasti, Luigina, Bozzini, Sara, Mongiardi, Christian, Tandurella, Nicolò, Corso, Rossana, Zerba, Francesco G., Squizzato, Alessandro, Campiotti, Leonardo, Dentali, Francesco, Klersy, Catherine, Grandi, Anna M., Falcone, Colomba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371567/ https://www.ncbi.nlm.nih.gov/pubmed/30755202 http://dx.doi.org/10.1186/s12933-019-0821-5 |
Ejemplares similares
-
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: a longitudinal study during atorvastatin treatment
por: Guasti, Luigina, et al.
Publicado: (2016) -
In vitro effects of Apixaban on 5 different cancer cell lines
por: Guasti, Luigina, et al.
Publicado: (2017) -
Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease
por: Falcone, Colomba, et al.
Publicado: (2013) -
Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis
por: Wu, Rui, et al.
Publicado: (2020) -
Microalbuminuria and sRAGE in High-Risk Hypertensive Patients Treated with Nifedipine/Telmisartan Combination Treatment: A Substudy of TALENT
por: Falcone, Colomba, et al.
Publicado: (2012)